Skip to main content
. 2023 Sep 22;56:e0382-2023. doi: 10.1590/0037-8682-0382-2023

TABLE 1B: Resistance profile of E. coli and K. pneumoniae ESBL producers.

Antimicrobial drug E. coli ESBL a resistance (n = 9) (%) K. pneumoniae ESBL resistance (n=15) (%)
Ceftriaxone 9 (100%) 15 (100%)
Cefepime 9 (100%) 12 (80%)
Ciprofloxacin 5 (55.5%) 12 (80%)
Gentamicin 4 (44.4%) 6 (40%)
Meropenem 0 0
Imipenem 0 0
Piperacillin-tazobactam 0 0

a ESBL: Extended spectrum beta lactamase.